(Total Views: 202)
Posted On: 02/24/2017 9:30:39 AM
Post# of 36550
$IMLFF closed up 2.72% on reversal.
$IMLFF InMed’s proprietary in silico drug/disease bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline are the fundamental value drivers of the Company. $VBIO $GWPH $AXIM
$IMLFF InMed’s proprietary in silico drug/disease bioinformatics assessment tool, cannabinoid biosynthesis technology and drug development pipeline are the fundamental value drivers of the Company. $VBIO $GWPH $AXIM
(0)
(0)
